Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers

Introduction: RTS,S/AS01 is currently the most advanced malaria vaccine but provides incomplete, short-term protection. It was developed for use within the expanded program on immunizations (EPI) for African children. Another use could be adding mass RTS,S/AS01 vaccination to the integrated malaria...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hum Vaccin Immunother
Main Authors: von Seidlein, Lorenz, Hanboonkunupakarn, Borimas, Jittamala, Podjanee, Pongsuwan, Pongphaya, Chotivanich, Kesinee, Tarning, Joel, Hoglund, Richard M., Winterberg, Markus, Mukaka, Mavuto, Peerawaranun, Pimnara, Sirithiranont, Pasathorn, Doran, Zoe, Ockenhouse, Christian F., Ivinson, Karen, Lee, Cynthia, Birkett, Ashley J., Kaslow, David C., Singhasivanon, Pratap, Day, Nicholas P.J., Dondorp, Arjen M., White, Nicholas J., Pukrittayakamee, Sasithon
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2019
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012096/
https://ncbi.nlm.nih.gov/pubmed/31306084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1643675
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki